Cancer Research and Patient Care Enhanced by Dr. Mannel's Re-Election

Robert Mannel, M.D., director of OU Health Stephenson Cancer Center and a professor of obstetrics and gynecology at the University of Oklahoma College of Medicine, has been re-elected as one of the group chairs of NRG Oncology, a leading organization in cancer research. This is great news for patients, as NRG Oncology's extensive experience and collaborative efforts focus on improving treatments for various cancers, including adult brain tumors, head and neck cancer, localized and locally advanced lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, and gynecologic cancer.

Dr. Mannel's leadership ensures that leading-edge research and clinical trials continue to advance, offering patients access to the latest and most effective cancer therapies. His re-election means a continued commitment to high-quality patient care and innovative cancer treatment options.

This work highlights the importance of the joint clinical, research, and educational missions of OU Health and the University of Oklahoma.

Read more from the University of Oklahoma about Dr. Mannel's re-election.

Mannel Re-Elected Chair of NRG Oncology